MYND Life Sciences Announces Patent Applications for Depression and Neuropsychiatric Disorder Drugs Jun 10, 2021
MINDCURE Successfully Completes First Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research Jun 3, 2021
PsyBio Therapeutics Reports First Quarter 2021 Financial Results, Provides Shareholder Update and Announces Intention to… Jun 1, 2021
MindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data on LSD to Help Guide Personalized Dosing May 26, 2021
7 Investment Tips from Kevin O’Leary, Who Says There’s More Money In Psychedelics Than There Is In Cannabis May 19, 2021
